Product Information
INSULIN GLARGINE MAX SOLO U300 is a generic product labeled by Sanofi-Aventis U.S. LLC, priced at $26.9895 per ML under NDC 00955290002. Its NADAC has been published 102 times since Apr 17, 2024.
Strength
300 [iU]/mL
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00955290002
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
INSULIN GLARGINEApproval Type
Biologic (BLA)
FDA Application
BLA206538On Market Since
4/1/2023
Pharmacological Classes
Price Statistics
The NADAC for INSULIN GLARGINE MAX SOLO U300 has been published 102 times since Apr 17, 2024, and over the history we have for it it has declined 26.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.9895 per ML |
|---|---|
| All-time high | $36.7953 (May 15, 2024) |
| All-time low | $26.9595 (Apr 22, 2026) |
| 52-week high | $36.6819 |
| 52-week low | $26.9595 |
| Median price | $36.6387 |
| Average price | $35.6823 |
| Largest weekly change | -26.4% (Apr 22, 2026) |
| Weeks tracked | 102 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of INSULIN GLARGINE MAX SOLO U300?
The current National Average Drug Acquisition Cost (NADAC) for INSULIN GLARGINE MAX SOLO U300, manufactured by Sanofi-Aventis U.S. LLC, is $26.9895 per ML (NDC 00955290002), effective Jun 24, 2026.
How has the price of INSULIN GLARGINE MAX SOLO U300 changed over time?
Over the history we have for it, the NADAC for INSULIN GLARGINE MAX SOLO U300 has declined 26.6%. It has been tracked across 102 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for INSULIN GLARGINE MAX SOLO U300?
Since Apr 17, 2024, the NADAC for INSULIN GLARGINE MAX SOLO U300 has ranged from a low of $26.9595 (Apr 22, 2026) to a high of $36.7953 (May 15, 2024), with a median of $36.6387 per ML.
Are there cheaper alternatives to INSULIN GLARGINE MAX SOLO U300?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as INSULIN GLARGINE MAX SOLO U300, but none are currently priced below it.
Who manufactures INSULIN GLARGINE MAX SOLO U300?
INSULIN GLARGINE MAX SOLO U300 (NDC 00955290002) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification